KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares IssuedShares OutstandingShares Outstanding
Ratios

Supernus Pharmaceuticals (SUPN) Shares Issued (2016 - 2026)

Supernus Pharmaceuticals has reported Shares Issued over the past 15 years, most recently at $8.6 million for Q4 2025.

  • Quarterly Shares Issued rose 24.43% to $8.6 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $37.6 million through Dec 2025, up 152.32% year-over-year, with the annual reading at $37.6 million for FY2025, 152.32% up from the prior year.
  • Shares Issued was $8.6 million for Q4 2025 at Supernus Pharmaceuticals, down from $23.7 million in the prior quarter.
  • Over five years, Shares Issued peaked at $23.7 million in Q3 2025 and troughed at $524000.0 in Q3 2021.
  • The 5-year median for Shares Issued is $2.4 million (2022), against an average of $3.9 million.
  • Year-over-year, Shares Issued skyrocketed 6921.88% in 2021 and then tumbled 88.54% in 2023.
  • A 5-year view of Shares Issued shows it stood at $1.6 million in 2021, then skyrocketed by 79.62% to $2.8 million in 2022, then tumbled by 61.4% to $1.1 million in 2023, then skyrocketed by 529.76% to $6.9 million in 2024, then grew by 24.43% to $8.6 million in 2025.
  • Per Business Quant, the three most recent readings for SUPN's Shares Issued are $8.6 million (Q4 2025), $23.7 million (Q3 2025), and $3.3 million (Q2 2025).